items_header

Open projects

Projects available to all portals

Nanofacile
Montreal, Quebec, Canada
CZ
Operations manager
Preferred learners
  • Quebec, Canada
  • Academic experience
Categories
Engineering & manufacturing Mechanical engineering
Skills
computer-aided design
Project scope
What is the main goal for this project?

We would like to collaborate with students to produce prototypes for new design ideas.

This will involve several different steps for the students, including:

  • Creating drawings and models using computer-aided design (CAD).
  • Updating prototypes based on feedback and design decisions.
  • Documenting details about design components.

Bonus steps in the process would also include:

  • Developing new design ideas for future prototyping.
What tasks will learners need to complete to achieve the project goal?

By the end of the project, students should demonstrate:

  • Familiarity with our goals and product.
  • Creation and updating of prototypes
  • Documentation of design choices and component functions

Bonus steps would include:

  • Developing ideas for future prototyping

Final deliverables should include

  • A final report.
  • A presentation.
How will you support learners in completing the project?

Students will connect directly with us for mentorship throughout the project. We will be able to provide answers to questions such as:

  • Our new and existing products and services
  • Input on choices, problems or anything else the students might encounter.
Supported causes
Industry, innovation and infrastructure
About the company

Vision
Accelerate the development of disruptive medicines.

Our mission
We simplify and de-risk targeted nanomedicine development for biotechnology innovators using our accessible technology and proven methods.

The problem
Developing nanomedicines is twice as expensive as normal therapies, expertise in this field is scarce, equipment is costly, and it takes a long time to bring these therapies to market. We aim to bridge the gap between great ideas and patients by de-risking and accelerating nanomedicine R&D.

The solution
Our approach is “nanomedicine in a box’' This includes recipes for ensuring targeted delivery. Our core intellectual property is an advanced microfluidic device that shortens preclinical development from weeks to days. Additionally, we offer a method for rapid therapy encapsulation, achievable in minutes. All these benefits come with minimal upfront investment, making our approach 10 times more cost-effective than that of our competitors.